Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
The European Equity Fund | EEA | 4. oct 2024 | 9.09 | -0.98 |
The First Bancshares | FBMS | 4. oct 2024 | 31.32 | +1.10 |
The Gabelli Healthcare & Wellness Trust | GRX | 4. oct 2024 | 10.92 | +0.37 |
The Gdl Fund | GDL | 4. oct 2024 | 8.14 | +0.02 |
The Glimpse Group | VRAR | 4. oct 2024 | 0.70 | -1.39 |
The Hackett Group | HCKT | 4. oct 2024 | 25.62 | +0.79 |
The Hain Celestial Group | HAIN | 4. oct 2024 | 8.72 | +1.99 |
The Hershey | HSY | 4. oct 2024 | 191.84 | +0.45 |
The Herzfeld Caribbean Basin Fund | CUBA | 4. oct 2024 | 2.29 | +2.47 |
The Honest Company | HNST | 4. oct 2024 | 3.55 | +1.72 |
The Intergroup | INTG | 4. oct 2024 | 16.40 | +7.61 |
The J.M Smucker Company | SJM | 4. oct 2024 | 117.39 | +0.09 |
The Joint | JYNT | 4. oct 2024 | 11.12 | +1.37 |
The Marygold Companies | MGLD | 4. oct 2024 | 1.45 | -4.92 |
The ODP | ODP | 4. oct 2024 | 30.47 | +1.77 |
The OLB Group | OLB | 4. oct 2024 | 2.50 | -9.75 |
The Oncology Institute | TOI | 4. oct 2024 | 0.32 | +1.82 |
The ONE Group Hospitality | STKS | 4. oct 2024 | 3.67 | +5.76 |
The Pennant Group | PNTG | 4. oct 2024 | 33.00 | -2.45 |
The Real Brokerage | REAX | 4. oct 2024 | 5.75 | +2.50 |
The Real Estate Select Sector SPDR Fund | XLRE | 4. oct 2024 | 43.52 | -0.66 |
The RealReal | REAL | 4. oct 2024 | 3.23 | +7.31 |
The RMR Group A | RMR | 4. oct 2024 | 25.49 | +1.76 |
The Shyft Group | SHYF | 4. oct 2024 | 11.99 | +0.25 |
The Trade Desk A | TTD | 4. oct 2024 | 113.00 | +1.38 |
The9 ADR | NCTY | 4. oct 2024 | 6.53 | +2.51 |
TherapeuticsMD | TXMD | 4. oct 2024 | 1.64 | +2.66 |
Theratechnologies | THTX | 4. oct 2024 | 1.20 | -0.38 |
Theravance Biopharma | TBPH | 4. oct 2024 | 8.10 | 0.00 |
Theriva Biologics | TOVX | 4. oct 2024 | 1.68 | -6.15 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.